Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Switzerland Tech Review.
Press releases published on June 5, 2025
Newsmatics Launches U.S. Politics Today on Substack, Delivering Global Perspectives on American Policy
EIN Presswire
·
June 5, 2025
The publication aims to highlight key issues in politics and underreported stories across domestic and global landscapes WASHINGTON , DC, UNITED STATES, June 5, 2025 /EINPresswire.com/ -- Newsmatics, a leading news technology company with innovative …
NewBlue Launches EMEA Fusion Line: Advanced Live Graphics Solutions for Broadcast, Sports, and Corporate Production
EIN Presswire
·
June 5, 2025
Empowering EMEA Creators with Cutting-Edge Live Graphics Technology for Every Production Environment. SAN DIEGO, CA, UNITED STATES, June 4, 2025 /EINPresswire.com/ -- NewBlue, a global leader in live video graphics innovation, is proud to unveil the …
Starke Verkaufszahlen für Cresemba® (Isavuconazol) in der Region Asien-Pazifik und China lösen weitere Meilensteinzahlung an Basilea aus
GlobeNewswire
·
June 5, 2025
Allschwil, 05. Juni 2025 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an schweren Infektionen durch Bakterien oder Pilze erkrankt sind, gab …
Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers further milestone payment to Basilea
GlobeNewswire
·
June 5, 2025
Allschwil, Switzerland, June 05, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the continued …
Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference
GlobeNewswire
·
June 5, 2025
Geneva, Switzerland, June 5, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that …